Read about the move to scale use of AI across all FDA centers by the end of June and learn more about future plans to expand ...

Q1 2025 Results Conference Call May 13, 2025 1:00 PM ETCompany ParticipantsPardeep Sangha - IRAlexander Dobranowski ...

There could be an upside to incorporating AI for the FDA. Using AI to assist in final drug reviews would "represent a chance ...

The United States government recently announced a plan to leverage a 100% tariff on "foreign" films. President Donald Trump ...

AI-powered tools are enhancing precision, efficiency, and decision-making in biopharmaceutical development. Recently, Jared ...

This article focuses on the common regulatory threads that connect different regions and the global standards and principles ...

Synchron announced that it will become the first brain-computer interface (BCI) maker to achieve native integration with an ...

According to recent findings by McKinsey, 78 percent of organisations globally have already adopted AI in some capacity, a ...

The FDA  plans to launch generative AI across all of its centers by June 30. The agency has also appointed its first chief AI ...

The licensing rights include the U.S., where the FDA regulates drug and medical device development, so both companies expect that an acquisition will unlock growth opportunities and drive sustained ...

The Food and Drug Administration is rolling out an aggressive plan to make generative AI a linchpin in its decision-making, ...

Supposedly, the AI tool will speed up the FDA's drug review process by reducing the time its scientists have to spend doing ...